CY1106227T1 - Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου - Google Patents

Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου

Info

Publication number
CY1106227T1
CY1106227T1 CY20061101572T CY061101572T CY1106227T1 CY 1106227 T1 CY1106227 T1 CY 1106227T1 CY 20061101572 T CY20061101572 T CY 20061101572T CY 061101572 T CY061101572 T CY 061101572T CY 1106227 T1 CY1106227 T1 CY 1106227T1
Authority
CY
Cyprus
Prior art keywords
composition
human birth
facilitating human
metaphosphates
sensation
Prior art date
Application number
CY20061101572T
Other languages
English (en)
Inventor
Andreas F. Schaub
Original Assignee
Hcb Happy Child Birth Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27671986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106227(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hcb Happy Child Birth Holding Ag filed Critical Hcb Happy Child Birth Holding Ag
Publication of CY1106227T1 publication Critical patent/CY1106227T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Χρησιμοποίηση μιας φυσιολογικά ακίνδυνης οργανικής ουσίας για την παρασκευή μιας σύνθεσης χωρίς περιεχόμενο σε άλατα αλκαλικών μετάλλων από μεταφωσφορικά άλατα για την εφαρμογή σαν λιπαντικό μέσο σε κολπικούς τοκετούς γυναικών. Με την σύνθεση μπορεί να διευκολύνεται και να επιταχύνεται η διαδικασία του τοκετού. Με προσμεμιγμένες φαρμακευτικές δραστικές ουσίες μπορεί για παράδειγμα επιπρόσθετα να γίνεται πρόληψη μολύνσεων και να επηρεάζεται η αίσθηση του πόνου.
CY20061101572T 2002-01-22 2006-11-01 Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου CY1106227T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH00121/02A CH697081A5 (de) 2002-01-22 2002-01-22 Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
PCT/EP2003/000548 WO2003066020A1 (de) 2002-01-22 2003-01-21 Zusammensetzung zur erleichterung der humangeburt

Publications (1)

Publication Number Publication Date
CY1106227T1 true CY1106227T1 (el) 2011-06-08

Family

ID=27671986

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101572T CY1106227T1 (el) 2002-01-22 2006-11-01 Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου

Country Status (13)

Country Link
US (1) US20050053670A1 (el)
EP (3) EP2255784A1 (el)
JP (1) JP4846198B2 (el)
AT (1) ATE336228T1 (el)
AU (1) AU2003229546A1 (el)
CA (1) CA2477053C (el)
CH (1) CH697081A5 (el)
CY (1) CY1106227T1 (el)
DE (2) DE20321512U1 (el)
DK (1) DK1467707T3 (el)
ES (1) ES2271572T3 (el)
PT (1) PT1467707E (el)
WO (1) WO2003066020A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP1886676A1 (en) * 2006-08-09 2008-02-13 Polichem S.A. Compositions with enhanced elasticizing activity
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CN104771790B (zh) * 2014-01-13 2018-02-09 成都英诺新科技有限公司 一种助产用凝胶的制备方法
WO2019059856A1 (en) 2017-09-22 2019-03-28 Turkuaz Sağlik Hi̇zmetleri̇ Medi̇kal Temi̇zli̇k Ki̇myasal Ürünler Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ OBSTETRIC GEL AND METHOD OF PRODUCTION
GB2615312A (en) * 2022-02-01 2023-08-09 Birthglide Ltd Birthing device
WO2023148486A1 (en) * 2022-02-01 2023-08-10 Birthglide Limited Birthing device

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496592A (en) 1969-04-24 1970-02-24 Judson O Jones Portable apparatus for cleaning and partially drying carpets
US3971848A (en) * 1970-12-21 1976-07-27 Kimitsu Chemical Laboratory Co. Ltd. Lubricating composition for mucosa or epidermis
JPS4948725B1 (el) * 1971-06-24 1974-12-23
US4184974A (en) * 1974-05-16 1980-01-22 Leuven James W Van Liquid biocidal compositions comprising a mixture of silver ions and sodium pectate
US4267168A (en) * 1977-03-11 1981-05-12 Aquatain Partnership Method of reducing bacteria on human tissue using liquid biocidal compositions comprising a mixture of silver ions and sodium pectate
GB8323624D0 (en) * 1983-09-02 1983-10-05 Reckitt & Colmann Prod Ltd Medicinal compositions
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
US4602623A (en) 1983-12-30 1986-07-29 Michael Cherkassky Method of delivering a fetus
GB8622698D0 (en) * 1986-09-20 1986-10-29 Smith & Nephew Ass Dispenser
US4859242A (en) * 1987-03-16 1989-08-22 Color Quest Inc. Water soluble coloring compositions containing sparkle components
US4981686A (en) * 1987-05-18 1991-01-01 Hardy Robert E Personal lubricant
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
US5342617A (en) * 1990-12-03 1994-08-30 Medical Polymers, Inc. Water-based human tissue lubricant
JP3042546B2 (ja) * 1991-04-23 2000-05-15 昭和電工株式会社 微粒子状の架橋型ｎ−ビニルアミド樹脂及びミクロゲル、その製造法及び用途
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
NL9400160A (nl) * 1994-02-02 1995-09-01 Stichting Tech Wetenschapp Therapeutische samenstelling voor het vervangen en/of aanvullen van lichaamsvloeistoffen.
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
DK0851908T3 (da) * 1995-06-07 2003-08-25 Lee County Mosquito Control Di Smøremiddelsammensætning og fremgangsmåde
DE19531893A1 (de) * 1995-08-30 1997-03-06 Bayer Ag Juckreizmildernde, kosmetische und/oder pharmazeutische Zusammensetzungen
US5885591A (en) * 1996-07-02 1999-03-23 Johnson & Johnson Consumer Products, Inc. Personal lubricant compositions
US5877209A (en) * 1996-11-07 1999-03-02 Yunis; Adel A. Hair follicle protective formulations
US6316011B1 (en) * 1998-08-04 2001-11-13 Madash, Llc End modified thermal responsive hydrogels
US6139848A (en) * 1999-02-12 2000-10-31 Mcneil-Ppc, Inc. Personal lubricant compositions
RU2177789C2 (ru) 1999-11-19 2002-01-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия LTD" Средство, способствующее созреванию шейки матки, способ ускорения созревания шейки матки и устройство для доставки лекарственного средства к шейке матки
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
WO2004026255A2 (en) * 2002-09-20 2004-04-01 La Jolla Biosciences Compositions and methods for preventing infection
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050181057A1 (en) * 2004-02-13 2005-08-18 Rosenberg Paul K. Vaginal lubricant

Also Published As

Publication number Publication date
DK1467707T3 (da) 2006-12-27
WO2003066020A1 (de) 2003-08-14
CA2477053C (en) 2012-07-24
JP4846198B2 (ja) 2011-12-28
DE20321512U1 (de) 2007-09-20
ATE336228T1 (de) 2006-09-15
CH697081A5 (de) 2008-04-30
EP1719502A1 (de) 2006-11-08
CA2477053A1 (en) 2003-08-14
US20050053670A1 (en) 2005-03-10
PT1467707E (pt) 2006-12-29
EP1467707A1 (de) 2004-10-20
AU2003229546A1 (en) 2003-09-02
DE50304651D1 (de) 2006-09-28
ES2271572T3 (es) 2007-04-16
EP2255784A1 (de) 2010-12-01
JP2005519071A (ja) 2005-06-30
EP1467707B1 (de) 2006-08-16

Similar Documents

Publication Publication Date Title
CY1106227T1 (el) Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
AR025045A1 (es) Composicion de ovulos intravaginales de clindamicina
SG162788A1 (en) Self-buffering protein formulations
NO20044699L (no) Vaginalpleiesammensetning
AR029655A1 (es) Mejoras en formulaciones en pasta
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
HRP20040059B1 (en) Treatment of nail infections with no
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
BRPI0611400B1 (pt) formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
CY1104971T1 (el) Παρασκευασμα αποϊνιδοτιδιου και g-csf και η χρηση του για να κινητοποιει αιμοποιητικους προγονους
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
ES2103493T3 (es) Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
PL402550A1 (pl) Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
PT1054681E (pt) Utilizacao de combinacoes de agentes activos consistindo de antibioticos e extractos vegetais contendo terfeno na medicina veterinaria